Drug firm Zydus Cadila on Tuesday said it has filed the
investigational new drug (IND) application for ZYIL1, positioned for
management of critically ill COVID-19 patients.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/zydus-cadila-files-investigational-new-drug-application-for-covid-19-treatment/articleshow/79015416.cms
No comments:
Post a Comment